Lv46
490 积分 2026-03-16 加入
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
1个月前
已完结
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer
1个月前
已完结
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow‐up
1个月前
已完结
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer
1个月前
已完结
Statin use and outcomes in advanced prostate cancer:Secondary analysis of the SPARTAN trial
1个月前
已完结
Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
1个月前
已完结
Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group
1个月前
已完结
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
1个月前
已关闭
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
1个月前
已完结
Long-term Results from the LEA Randomized Trial: Extended Versus Standard Lymph Node Dissection in Patients with Bladder Cancer Undergoing Radical Cystectomy
1个月前
已完结
皖公网安备34019202002308
